Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents
- PMID: 33086717
- PMCID: PMC7588960
- DOI: 10.3390/jcm9103355
Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents
Abstract
Recently, sarcopenia was identified as a risk factor for non-alcoholic fatty liver disease (NAFLD) in adults. We here investigated the association between skeletal muscle mass (SMM) and NAFLD in non-obese children and adolescents. A retrospective medical chart review was performed for individuals aged 9-15 years diagnosed with NAFLD. Healthy volunteers aged 9-15 years were recruited as controls. Participants were subject to laboratory tests, abdominal sonography, and multi-frequency bioelectrical impedance analysis. SMM data were calculated as the skeletal muscle-to-body fat ratio (MFR), and the diagnosis of fatty liver was established by abdominal sonography. The control and NAFLD groups included 73 and 53 individuals, respectively. No significant difference was observed in gender and body mass index (BMI) distribution between the groups. Mean MFR was significantly lower in individuals with NAFLD than in those without (0.83 vs. 1.04, p = 0.005). After adjusting for age, sex, BMI, and serum glucose, the risk of having NAFLD was significantly associated with a decreased MFR (p = 0.016). NAFLD is significantly associated with relatively low SMM in non-obese children and adolescents. Increasing SMM, such as weight training, can be suggested as one of the treatment strategies in pediatric NAFLD without obesity.
Keywords: children; muscle-to-body fat ratio; non-alcoholic fatty liver disease; sarcopenia; skeletal muscle mass.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Relationship of the Degree of Sarcopenia with the Severity of Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk in Adolescents.Life (Basel). 2024 Nov 10;14(11):1457. doi: 10.3390/life14111457. Life (Basel). 2024. PMID: 39598255 Free PMC article.
-
Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.Gut Liver. 2019 Jan 15;13(1):67-76. doi: 10.5009/gnl18070. Gut Liver. 2019. PMID: 30037166 Free PMC article.
-
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10. J Bone Miner Res. 2019. PMID: 31074909 Free PMC article.
-
Sarcopenia and fatty liver disease.Hepatol Int. 2019 Nov;13(6):674-687. doi: 10.1007/s12072-019-09996-7. Epub 2019 Nov 8. Hepatol Int. 2019. PMID: 31705444 Review.
-
Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.World J Gastroenterol. 2017 Mar 14;23(10):1747-1757. doi: 10.3748/wjg.v23.i10.1747. World J Gastroenterol. 2017. PMID: 28348479 Free PMC article. Review.
Cited by
-
Association between Regional Body Muscle Mass and Non-Alcoholic Fatty Liver Disease: An Observational Study Using Data from the REACTION Study.J Pers Med. 2023 Jan 25;13(2):209. doi: 10.3390/jpm13020209. J Pers Med. 2023. PMID: 36836444 Free PMC article.
-
Association of Body Composition and Sarcopenia with NASH in Obese Patients.J Clin Med. 2021 Aug 3;10(15):3445. doi: 10.3390/jcm10153445. J Clin Med. 2021. PMID: 34362228 Free PMC article.
-
Preoperative myopenia and myosteatosis and their impact on postoperative complications in children with inflammatory bowel disease.Surg Today. 2023 Apr;53(4):483-489. doi: 10.1007/s00595-022-02596-3. Epub 2022 Oct 11. Surg Today. 2023. PMID: 36219246
-
Association of ultrasound signs of sarcopenia with serum ferritin levels and hepatic indices like NFS and FIB-4 in NAFLD patients.BMC Gastroenterol. 2025 Apr 15;25(1):261. doi: 10.1186/s12876-025-03773-7. BMC Gastroenterol. 2025. PMID: 40234765 Free PMC article.
-
A bibliometric analysis of metabolic dysfunction-associated steatotic liver disease in children from 2004 to 2024.Front Pediatr. 2025 Apr 28;13:1468788. doi: 10.3389/fped.2025.1468788. eCollection 2025. Front Pediatr. 2025. PMID: 40356777 Free PMC article. Review.
References
-
- Jou J., Choi S.S., Diehl A.M. Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease. Thieme Medical Publishers; New York, NY, USA: 2008. pp. 370–379. - PubMed
LinkOut - more resources
Full Text Sources